85 related articles for article (PubMed ID: 21737486)
21. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of a fixed-dose combination of trandolapril-verapamil in obese hypertensive patients resistant to monotherapy.
Rubio-Guerra AF; Lozano-Nuevo JJ; Vargas-Ayala G; Rodríguez-López L; Ramos-Brizuela LM; Escalante-Acosta BA
Clin Exp Hypertens; 2006 Oct; 28(7):619-24. PubMed ID: 17060060
[TBL] [Abstract][Full Text] [Related]
25. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
26. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
[TBL] [Abstract][Full Text] [Related]
27. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
[TBL] [Abstract][Full Text] [Related]
28. Trandolapril / verapamil SR combination reverses drug-induced new-onset diabetes.
Cardiovasc J Afr; 2008; 19(2):118. PubMed ID: 18516363
[No Abstract] [Full Text] [Related]
29. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
[TBL] [Abstract][Full Text] [Related]
30. Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial.
Ruggenenti P; Fassi A; Ilieva A; Iliev IP; Chiurchiu C; Rubis N; Gherardi G; Ene-Iordache B; Gaspari F; Perna A; Cravedi P; Bossi A; Trevisan R; Motterlini N; Remuzzi G;
J Hypertens; 2011 Feb; 29(2):207-16. PubMed ID: 21243736
[TBL] [Abstract][Full Text] [Related]
31. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
Scholze J; Zilles P; Compagnone D
Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
[TBL] [Abstract][Full Text] [Related]
32. Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients.
Nakou E; Filippatos TD; Liberopoulos EN; Tselepis AD; Kiortsis DN; Mikhailidis DP; Elisaf MS
Expert Opin Pharmacother; 2008 Jul; 9(10):1629-39. PubMed ID: 18570597
[TBL] [Abstract][Full Text] [Related]
33. Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.
Sharma SK; Ruggenenti P; Remuzzi G
Vasc Health Risk Manag; 2007; 3(4):453-65. PubMed ID: 17969376
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effect of combination therapy using an angiotensin-converting enzyme inhibitor plus verapamil on circulating resistin levels in hypertensive patients with type 2 diabetes.
Rubio-Guerra AF; Vargas-Robles H; Lozano Nuevo JJ; Elizalde-Barrera CI; Huerta-Ramirez S; Escalante-Acosta BA
Exp Clin Cardiol; 2012; 17(4):202-4. PubMed ID: 23592936
[TBL] [Abstract][Full Text] [Related]
35. Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.
Schneider M; Lerch M; Papiri M; Buechel P; Boehlen L; Shaw S; Risen W; Weidmann P
J Hypertens; 1996 May; 14(5):669-77. PubMed ID: 8762212
[TBL] [Abstract][Full Text] [Related]
36. Individual and combined effects of verapamil or trandolapril on attenuating hypertensive glomerulopathic changes in the stroke-prone rat.
Münter K; Hergenröder S; Jochims K; Kirchengast M
J Am Soc Nephrol; 1996 May; 7(5):681-6. PubMed ID: 8738802
[TBL] [Abstract][Full Text] [Related]
37. Once-daily fixed dose combinations of verapamil and trandolapril in black patients with mild to moderate hypertension: a new choice for first line treatment.
Skoularigis J; Strugo V; Radevski I; Hlatswayo Z; Sareli P
Int J Clin Pharmacol Ther; 1997 Feb; 35(2):51-5. PubMed ID: 9147707
[TBL] [Abstract][Full Text] [Related]
38. Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension.
Reynolds NA; Wagstaff AJ; Keam SJ
Drugs; 2005; 65(13):1893-914. PubMed ID: 16114984
[TBL] [Abstract][Full Text] [Related]
39. A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study.
Atalar E; Eskin F; Tugtekin HB; Karabulut A; Kanyilmaz S; Kirbiyik H; Ozyildiz AG
Biomed Res Int; 2020; 2020():2123601. PubMed ID: 32964020
[TBL] [Abstract][Full Text] [Related]
40. INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.
Cooper-DeHoff RM; Handberg EM; Mancia G; Zhou Q; Champion A; Legler UF; Pepine CJ
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1329-40. PubMed ID: 19900016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
